Connexin 43 inhibition sensitizes chemoresistant glioblastoma cells to temozolomide

Resistance of glioblastoma (GBM) to the front-line chemotherapeutic agent temozolomide (TMZ) continues to challenge GBM treatment efforts. The repair of TMZ-induced DNA damage by O-6-methylguanine-DNA methyltransferase (MGMT) confers one mechanism of TMZ resistance. Paradoxically, MGMT-deficient GBM...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Res
Main Authors: Murphy, Susan F, Varghese, Robin T, Lamouille, Samy, Guo, Sujuan, Pridham, Kevin J, Kanabur, Pratik, Osimani, Alyssa M, Sharma, Shaan, Jourdan, Jane, Rodgers, Cara M, Simonds, Gary R, Gourdie, Robert G, Sheng, Zhi
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5113032/
https://ncbi.nlm.nih.gov/pubmed/26542214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-15-1286
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados